Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2021-06-10
2022-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study of Cranial Electrotherapy Stimulation[CES] for Generalized Anxiety Disorder
NCT00539357
Generalized Anxiety Therapy Effectiveness
NCT05748652
Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care
NCT00765219
Internet Delivered Cognitive Behavior Therapy Based on Intolerance of Uncertainty
NCT05820568
Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder
NCT05792930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Paper Baseline
Half of the participants will complete the GAD 7 in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the GAD 7 on the Mirror device equipped with Amazon Alexa.
Paper GAD 7
The paper based GAD 7 that is commonly accepted at clinics
Voice Administered GAD 7
This is the voice based GAD 7 that is administered through a Mirror device equipped with Amazon Alexa software.
Alexa Baseline
The other half of the participants will complete the GAD 7 on the Mirror device equipped with Amazon in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the GAD 7 in the traditional paper format.
Paper GAD 7
The paper based GAD 7 that is commonly accepted at clinics
Voice Administered GAD 7
This is the voice based GAD 7 that is administered through a Mirror device equipped with Amazon Alexa software.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paper GAD 7
The paper based GAD 7 that is commonly accepted at clinics
Voice Administered GAD 7
This is the voice based GAD 7 that is administered through a Mirror device equipped with Amazon Alexa software.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Individuals who are not their own guardian (i.e., those suffering from severe disabilities) will also be excluded.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oral Roberts University
UNKNOWN
Oklahoma State University Center for Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason Beaman, D.O.
Role: PRINCIPAL_INVESTIGATOR
Oklahoma State University Center for Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OSU Behavioral Health Clinic
Tulsa, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.